- Approach Resources Inc. stock price today and history
Please, Signup (Login) to subscribe or trade (demo)
Approach Resources Inc. stock price
Approach Resources Inc. latest news:
ADM has made takeover approach to Bunge: WSJ
(Reuters) - Agricultural processing and trading company Archer Daniels Midland Co has proposed a takeover of Bunge Ltd , the Wall Street Journal reported on Friday, a move that could set up a battle for Bunge with London-based rival Glencore Plc in an industry moving toward consolidation.
UPDATE 3-ADM has made takeover approach to Bunge -WSJ
Jan 19 (Reuters) - Agricultural processing and trading
company Archer Daniels Midland Co has proposed a
takeover of Bunge Ltd, the Wall Street Journal reported
on Friday, a move that could set up a battle for Bunge with
London-based rival Glencore Plc in an industry moving
ADM has made takeover approach to Bunge -WSJ
Agricultural processing and trading company Archer Daniels Midland Co (ADM) has proposed a takeover of Bunge Ltd (BG), the Wall Street Journal reported on Friday, a move that could set up a battle for Bunge (BG) with London-based rival Glencore Plc (GLCNF) . Bunge (BG) and other top grains traders - who make money by buying, selling, storing, shipping and trading crops - are struggling to adapt to a world of oversupply.
Archer Daniels has made takeover approach to Bunge: WSJ
(Reuters) - Agricultural trader Archer Daniels Midland Co made a takeover approach to rival Bunge Ltd , the Wall Street Journal reported on Friday, citing people familiar with the matter. http://on.wsj.com/2mSY8L0
UPDATE 1-Archer Daniels has made takeover approach to Bunge - WSJ
Jan 19 (Reuters) - Agricultural trader Archer Daniels
Midland Co made a takeover approach to rival Bunge Ltd
, the Wall Street Journal reported on Friday, citing
people familiar with the matter. http://on.wsj.com/2mSY8L0
BRIEF-Canadian Pacific Railway Reports Q4 Earnings Per Share of C$6.77
* CP REPORTS RECORD FOURTH-QUARTER AND RECORD FULL-YEAR
THE STRENGTH OF ITS OPERATING MODEL AND DISCIPLINED APPROACH IN
NY Fed chief tells FT that central bank should review inflation target
New York Fed President Bill Dudley told the Financial Times the central bank should review its inflation target, which is 2%. In the context of how the Fed could act if rates again approach zero, he said it was worth considering whether to shift to a price-level target. The report also said the Fed could consider moving to an inflation target range of 1.5% to 2.5%. Dudley told the newspaper he was against increasing the inflation target to 4%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Entire operation of federal consumer regulator under review
Acting director of Consumer Financial Protection Bureau calls for review of entire structure and approach of federal government's consumer watchdog agency
Nearly two dozen attorneys general sue to block FCC's repeal of net neutrality rules
The expected wave of litigation is part of a three-pronged approach to undue the repeal.
Brown's final budget plan proposes $132 billion in spending
Democratic Gov. Jerry Brown said Wednesday California will have one of the largest budget surpluses since the Great Recession but proposed spending almost none of it, sticking with his restrained approach to spending in his final budget plan.
Asian shares approach 2007 peak, dollar weak on soft inflation prospects
TOKYO (Reuters) - Asian shares inched closer to their record 2007 peak on Friday as U.S. jobs data pointed to firm economic growth although the greenback was soft as the spectre of benign inflation capped domestic bond yields.
GLOBAL MARKETS-Asian shares approach 2007 peak, dollar weak on soft inflation prospects
TOKYO, Jan 5 (Reuters) - Asian shares inched closer to their
record 2007 peak on Friday as U.S. jobs data pointed to firm
economic growth although the greenback was soft as the spectre
of benign inflation capped domestic bond yields.
AveXis could be lifted by rival Spark Therapeutics' pricing scheme for gene therapy: RBC
Biotech AveXis Inc. could benefit, if indirectly, from payment arrangements set up by rival Spark Therapeutics Inc. for its $850,000-a-patient gene therapy Luxturna, RBC Capital Markets analyst Brian Abrahams said on Wednesday. AveXis, which is developing its AVXS-101 gene therapy as a one-time treatment for spinal muscular atrophy, saw shares decline 3.6% in heavy Wednesday trade. AVXS-101, if approved, could cost as much as $2 million per treatment, Abrahams said. The payment schemes set up by Spark, intended to make Luxturna's record-setting pricetag more palatable to health care payers, "helps set the stage for AVXS's '101 and other gene therapies," Abrahams said. "We note this strategy is in distinct contrast to what had taken place with other one-time treatments as in HCV, and believe that this more proactive approach is more likely to ensure the buy-in of key constituents (rather than generate a backlash)." Positive results from a phase 1 trial of AVXS-101 were published in the New England Journal of Medicine in November, and Abrahams said that the Food and Drug Administration might consider accelerated approval. Abrahams also raised his price target for AveXis from $97 to $99 on Wednesday, citing the success of Biogen's spinal muscular atrophy therapy Spinraza, among other factors. AveXis shares have surged 8.4% over the last three months, compared with a 6.9% rise in the S&P 500 and a 9.6% rise in the Dow Jones Industrial Average .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
UK office firm IWG gets bid approach from Canada's Onex, Brookfield
British serviced office provider IWG Plc (IWGFF) has received a bid approach from Canadian private equity firm Onex and Brookfield Asset Management (BAM), it said on Wednesday. IWG, the company behind the Regus brand that runs offices in about 3,000 locations in over 1,000 cities, did not disclose any further details about the possible cash offer.
UPDATE 1-UK office firm IWG gets bid approach from Canada's Onex, Brookfield
Dec 27 (Reuters) - British serviced office provider IWG Plc
has received a bid approach from Canadian private equity
firm Onex and Brookfield Asset Management, it said on
Monthly expenses: 60 minutes to better budgeting in 2018
A new year means a new approach to staying on top of your finances. Here's how to put a budget together in a mere hour or less.
MOVES-JPMorgan's Dimon adds public policy chief Scher to executive panel
JPMorgan Chase & Co CEO Jamie Dimon on Thursday added Peter Scher, global head of corporate responsibility, to the bank's 10-member operating committee of top executives. In an employee memo, which was seen by Reuters, Dimon said he named Scher to the panel to ensure a "coordinated approach to our broad-based community engagement, government relations and overall public policy efforts."
Stocks open higher to approach record levels
Stock indexes opened higher on Thursday to trade near record levels. Market activity could be subdued as investors look beyond the tax bill for fresh reasons to snap up equities. The Dow Jones Industrial Average advanced 75 points, or 0.3%, to 24,802. The S&P 500 was up 8 points, or 0.3%, to 2,687. The Nasdaq Composite Index added 17 points, or 0.2%, to 6,978.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
A business approach to improving schools in India will mean investment is directly linked to pupil achievement.
Gene-therapy approach to hemophilia finds success in study, Spark stock surges
Spark Therapeutics Inc. stock surged Wednesday afternoon after the company announced positive results from a study of a gene-therapy approach to hemophilia. The drug, developed and tested in a collaboration with Pfizer Inc. , involves a single injection meant to help those suffering from hemophilia B, a disease that keep blood from clotting and is typically treated with regular and costly infusions. The study followed 10 adult males for 492 weeks and found that the number of episodes of bleeding decreased from an average of 11.1 a year before administration to 0.4 per year after, while infusions were reduced by 99%. The results were published in The New England Journal of Medicine on Wednesday, the companies said in a news release. Spark shares jumped as much as 9% in late trading after the announcement Wednesday, while Pfizer shares were unchanged.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Unilever CEO defends balance between growth, margin
Unilever Chief Executive Paul Polman on Thursday defended his balancing of growth and margin, weighing in passionately after a weak third quarter on a debate sparked by this year's unwanted approach from Kraft-Heinz.
YouTube sharpens how it recommends videos despite fears of isolating users
Google's YouTube has updated its recommendation feature to spotlight videos users are likely to find the most gratifying, brushing aside concerns that such an approach can trap people in bubbles of misinformation and like-minded opinions.
BRIEF-UnitedHealth Group Sees 2017 Adjusted Net Earnings To Approach $10 Per Share
* UNITEDHEALTH GROUP TO DISCUSS BUSINESS OUTLOOK AT INVESTOR
Uber execs travel world to reassure regulators after controversies
* Uber has changed approach in dealing with regulators - Asia head. * Ride-hailing firm has been embroiled in string of controversies. Uber executives are travelling the globe to reassure regulators that the company is changing the way it does business, after a string of controversies hurt the ride-hailing firm's reputation, its Asian head said on Monday.
2017 Data Breaches Approach 1,200 Incidents
Exclusive: Mattel snubs Hasbro's latest acquisition approach - sources
(Reuters) - Mattel Inc has rebuffed Hasbro Inc's latest takeover approach, people familiar with the matter said on Wednesday, casting uncertainty over the potential combination of the world's two largest toy companies.
UK Stocks-Factors to watch on Nov 15
Nov 15 (Reuters) - Britain's FTSE 100 index is seen opening down 4
points at 7,410.4 on Wednesday, according to financial bookmakers.
* ASTRAZENECA: Anglo-Swedish pharmaceutical firm AstraZeneca Plc on
Tuesday said the U.S. Food and Drug Administration approved its drug
Benralizumab, as an add-on treatment for patients with severe asthma aged 12
years and older.
* GOCMOPARE-ZPG: British company GoCompare has rejected a 460
million pound ($600 million) takeover approach made by
Fed may need 'extreme' policy to deal with future shocks: Evans
Chicago Federal Reserve Bank President Charles Evans on Tuesday became the second Fed policymaker in recent days to call for a new approach to rate-setting that would allow the central bank to respond to shocks when interest-rate cuts alone are not enough.
U.S. toymaker Hasbro makes new approach to buy Mattel: source
(Reuters) - Hasbro Inc has made an approach to acquire rival Mattel Inc , a source familiar with the matter said on Friday, the latest attempt to combine the two biggest U.S. toymakers in more than two decades.
U.S. toymaker Hasbro makes takeover approach for Mattel: WSJ
(Reuters) - U.S. toymaker Hasbro Inc has made a takeover approach for rival Mattel Inc , the Wall Street Journal reported on Friday, citing people familiar with the matter.
Apricus Biosciences, IncAPRI
Aptose Biosciences, Inc.APTO
Aqua Metals, Inc.AQMS
Aquinox Pharmaceuticals, Inc.AQXP
AR Capital Acquisition Corp.AUMA
AR Capital Acquisition Corp.AUMAU
AR Capital Acquisition Corp.AUMAW
Aratana Therapeutics, Inc.PETX
Arbutus Biopharma CorporationABUS